Lyra Therapeutics, Inc. - Common Stock, $0.001 par value (LYRA)
CUSIP: 55234L105
Q2 2021 13F Holders as of 30 Jun 2021
- Type / Class
- Equity / Common Stock, $0.001 par value
- Shares outstanding
- 1,644,695
- Total 13F shares
- 6,979,450
- Share change
- -579,249
- Total reported value
- $56,043,000
- Price per share
- $8.03
- Number of holders
- 38
- Value change
- -$6,441,557
- Number of buys
- 13
- Number of sells
- 36
Quarterly Holders Quick Answers
What is CUSIP 55234L105?
CUSIP 55234L105 identifies LYRA - Lyra Therapeutics, Inc. - Common Stock, $0.001 par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 55234L105:
Top shareholders of LYRA - Lyra Therapeutics, Inc. - Common Stock, $0.001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
196%
|
3,222,560
|
$37,349,000 | — | 31 Mar 2021 | |
| Polaris Venture Management Co. V, L.L.C. |
13F
|
Company |
67%
|
1,100,852
|
$12,759,000 | — | 31 Mar 2021 | |
| Ikarian Capital, LLC |
13F
|
Company |
47%
|
780,728
|
$9,048,000 | — | 31 Mar 2021 | |
| Soleus Capital Management, L.P. |
13F
|
Company |
29%
|
475,814
|
$5,515,000 | — | 31 Mar 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
21%
|
348,394
|
$4,038,000 | — | 31 Mar 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
13%
|
211,886
|
$2,456,000 | — | 31 Mar 2021 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
9%
|
147,400
|
$1,709,000 | — | 31 Mar 2021 | |
| ArrowMark Colorado Holdings LLC |
13F
|
Company |
8.5%
|
139,187
|
$1,613,000 | — | 31 Mar 2021 | |
| MORGAN STANLEY |
13F
|
Company |
6.5%
|
107,195
|
$1,242,000 | — | 31 Mar 2021 | |
| STATE STREET CORP |
13F
|
Company |
5.9%
|
96,246
|
$1,115,000 | — | 31 Mar 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
5.5%
|
90,281
|
$1,046,000 | — | 31 Mar 2021 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
5.1%
|
83,650
|
$970,000 | — | 31 Mar 2021 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
4.9%
|
80,799
|
$936,000 | — | 31 Mar 2021 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
4.4%
|
72,052
|
$835,000 | — | 31 Mar 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
3.9%
|
64,451
|
$746,000 | — | 31 Mar 2021 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
3.7%
|
61,310
|
$711,000 | — | 31 Mar 2021 | |
| BLAIR WILLIAM & CO/IL |
13F
|
Company |
3.3%
|
55,000
|
$637,000 | — | 31 Mar 2021 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
3%
|
49,000
|
$568,000 | — | 31 Mar 2021 | |
| MARSHALL WACE, LLP |
13F
|
Company |
2.9%
|
46,928
|
$544,000 | — | 31 Mar 2021 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
2.6%
|
42,440
|
$491,000 | — | 31 Mar 2021 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
2.4%
|
39,167
|
$454,000 | — | 31 Mar 2021 | |
| ENVESTNET ASSET MANAGEMENT INC |
13F
|
Company |
2.2%
|
36,792
|
$426,000 | — | 31 Mar 2021 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
2%
|
32,364
|
$374,000 | — | 31 Mar 2021 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
1.9%
|
31,434
|
$364,000 | — | 31 Mar 2021 | |
| Pentwater Capital Management LP |
13F
|
Company |
1.4%
|
23,800
|
$276,000 | — | 31 Mar 2021 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
1.1%
|
17,913
|
$208,000 | — | 31 Mar 2021 | |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC |
13F
|
Company |
1%
|
16,961
|
$197,000 | — | 31 Mar 2021 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.91%
|
15,036
|
$174,000 | — | 31 Mar 2021 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.86%
|
14,177
|
$165,000 | — | 31 Mar 2021 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.75%
|
12,340
|
$143,000 | — | 31 Mar 2021 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.67%
|
10,943
|
$127,000 | — | 31 Mar 2021 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.63%
|
10,287
|
$119,000 | — | 31 Mar 2021 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.27%
|
4,438
|
$51,000 | — | 31 Mar 2021 | |
| AMERICAN INTERNATIONAL GROUP, INC. |
13F
|
Company |
0.24%
|
3,965
|
$46,000 | — | 31 Mar 2021 | |
| UBS Group AG |
13F
|
Company |
0.17%
|
2,754
|
$32,000 | — | 31 Mar 2021 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.14%
|
2,223
|
$25,000 | — | 31 Mar 2021 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.13%
|
2,085
|
$24,000 | — | 31 Mar 2021 | |
| HARBOUR INVESTMENTS, INC. |
13F
|
Company |
0.08%
|
1,315
|
$15,000 | — | 31 Mar 2021 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.06%
|
1,050
|
$13,000 | — | 31 Mar 2021 | |
| STRS OHIO |
13F
|
Company |
0.07%
|
1,100
|
$12,000 | — | 31 Mar 2021 | |
| Legal & General Group Plc |
13F
|
Company |
0.05%
|
759
|
$9,000 | — | 31 Mar 2021 | |
| CITIGROUP INC |
13F
|
Company |
0.04%
|
671
|
$8,000 | — | 31 Mar 2021 | |
| Cardinal Capital Management, Inc. |
13F
|
Company |
0.04%
|
650
|
$8,000 | — | 31 Mar 2021 | |
| Laurel Wealth Advisors LLC |
13F
|
Company |
0.03%
|
500
|
$6,000 | — | 31 Mar 2021 | |
| US BANCORP \DE\ |
13F
|
Company |
0.03%
|
500
|
$6,000 | — | 31 Mar 2021 | |
| Ameritas Investment Partners, Inc. |
13F
|
Company |
0.02%
|
363
|
$4,000 | — | 31 Mar 2021 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0.01%
|
192
|
$2,000 | — | 31 Mar 2021 | |
| Sargent Bickham Lagudis LLC |
13F
|
Company |
0.01%
|
100
|
$1,000 | — | 31 Mar 2021 | |
| TOTH FINANCIAL ADVISORY CORP |
13F
|
Company |
0.01%
|
100
|
$1,000 | — | 31 Mar 2021 |
Institutional Holders of Lyra Therapeutics, Inc. - Common Stock, $0.001 par value (LYRA) as of Q2 2021
As of 30 Jun 2021,
Lyra Therapeutics, Inc. - Common Stock, $0.001 par value (LYRA) was held by
38 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,979,450 shares.
The largest 10 holders included
PERCEPTIVE ADVISORS LLC, Polaris Venture Management Co. V, L.L.C., Ikarian Capital, LLC, PURA VIDA INVESTMENTS, LLC, VANGUARD GROUP INC, Soleus Capital Management, L.P., MILLENNIUM MANAGEMENT LLC, ArrowMark Colorado Holdings LLC, MORGAN STANLEY, and BOOTHBAY FUND MANAGEMENT, LLC.
This page lists
38
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2021 vs Q1 2021 Across Filers
Q1 2021 holders
49
Q2 2021 holders
38
Holder diff
-11
| Investor | Q1 2021 Shares | Q2 2021 Shares | Share Diff | Share Chg % | Q1 2021 Value $ | Q2 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.